Although serum concentrations of IgA in type 1 AIP/IgG4-RD patients were lower than those in CP patients, this difference was not statistically significant (Fig. 1 and Supplementary Table S1). Here, CD79A is linked to immunoglobulin G4-related sclerosing disease.